nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP2C18—malignant glioma	0.289	0.421	CbGaD
Imipramine—CYP2B6—malignant glioma	0.214	0.313	CbGaD
Imipramine—SLC6A3—malignant glioma	0.183	0.266	CbGaD
Imipramine—CYP1A2—Carmustine—malignant glioma	0.0305	0.57	CbGbCtD
Imipramine—CYP3A4—Temozolomide—malignant glioma	0.0231	0.43	CbGbCtD
Imipramine—HTR2C—choroid plexus—malignant glioma	0.00778	0.0857	CbGeAlD
Imipramine—HTR2A—choroid plexus—malignant glioma	0.0039	0.043	CbGeAlD
Imipramine—Vasospasm—Carmustine—malignant glioma	0.00307	0.0444	CcSEcCtD
Imipramine—ORM1—vertebral column—malignant glioma	0.00306	0.0337	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—malignant glioma	0.00236	0.026	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—malignant glioma	0.00228	0.0251	CbGeAlD
Imipramine—HTR7—pons—malignant glioma	0.00223	0.0245	CbGeAlD
Imipramine—Tongue discolouration—Temozolomide—malignant glioma	0.0021	0.0303	CcSEcCtD
Imipramine—HTR2A—cerebellar cortex—malignant glioma	0.00197	0.0216	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—malignant glioma	0.00192	0.0211	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—malignant glioma	0.00183	0.0202	CbGeAlD
Imipramine—Skin hyperpigmentation—Carmustine—malignant glioma	0.00176	0.0255	CcSEcCtD
Imipramine—DRD2—telencephalic ventricle—malignant glioma	0.00173	0.0191	CbGeAlD
Imipramine—Digestion impaired—Temozolomide—malignant glioma	0.00152	0.0219	CcSEcCtD
Imipramine—KCND2—brainstem—malignant glioma	0.00144	0.0158	CbGeAlD
Imipramine—HTR2A—pons—malignant glioma	0.00139	0.0153	CbGeAlD
Imipramine—HTR2A—vertebral column—malignant glioma	0.00138	0.0152	CbGeAlD
Imipramine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00135	0.0195	CcSEcCtD
Imipramine—KCND2—telencephalon—malignant glioma	0.00127	0.014	CbGeAlD
Imipramine—KCND3—brainstem—malignant glioma	0.00125	0.0138	CbGeAlD
Imipramine—Petechiae—Temozolomide—malignant glioma	0.00123	0.0178	CcSEcCtD
Imipramine—Endocrine disorder—Temozolomide—malignant glioma	0.00122	0.0177	CcSEcCtD
Imipramine—Speech disorder—Carmustine—malignant glioma	0.00122	0.0176	CcSEcCtD
Imipramine—Speech disorder—Temozolomide—malignant glioma	0.00118	0.017	CcSEcCtD
Imipramine—HTR2A—telencephalic ventricle—malignant glioma	0.00114	0.0126	CbGeAlD
Imipramine—KCND3—telencephalon—malignant glioma	0.00111	0.0122	CbGeAlD
Imipramine—Coordination abnormal—Carmustine—malignant glioma	0.00107	0.0154	CcSEcCtD
Imipramine—Coordination abnormal—Temozolomide—malignant glioma	0.00103	0.0149	CcSEcCtD
Imipramine—KCND2—medulla oblongata—malignant glioma	0.001	0.011	CbGeAlD
Imipramine—HTR2A—pineal body—malignant glioma	0.000992	0.0109	CbGeAlD
Imipramine—HTR7—endothelium—malignant glioma	0.000984	0.0108	CbGeAlD
Imipramine—HTR6—telencephalon—malignant glioma	0.000947	0.0104	CbGeAlD
Imipramine—Gynaecomastia—Carmustine—malignant glioma	0.000939	0.0136	CcSEcCtD
Imipramine—KCND2—midbrain—malignant glioma	0.000915	0.0101	CbGeAlD
Imipramine—HTR7—blood vessel—malignant glioma	0.000907	0.00999	CbGeAlD
Imipramine—KCND2—spinal cord—malignant glioma	0.000893	0.00983	CbGeAlD
Imipramine—Vascular purpura—Temozolomide—malignant glioma	0.000823	0.0119	CcSEcCtD
Imipramine—KCND3—midbrain—malignant glioma	0.000798	0.00878	CbGeAlD
Imipramine—Hot flush—Temozolomide—malignant glioma	0.000787	0.0114	CcSEcCtD
Imipramine—Menopausal symptoms—Temozolomide—malignant glioma	0.00078	0.0113	CcSEcCtD
Imipramine—Purpura—Temozolomide—malignant glioma	0.000764	0.011	CcSEcCtD
Imipramine—ADRA1D—telencephalon—malignant glioma	0.000739	0.00814	CbGeAlD
Imipramine—Affect lability—Temozolomide—malignant glioma	0.000724	0.0105	CcSEcCtD
Imipramine—KCND2—central nervous system—malignant glioma	0.000724	0.00797	CbGeAlD
Imipramine—Ataxia—Carmustine—malignant glioma	0.000716	0.0103	CcSEcCtD
Imipramine—KCND2—cerebellum—malignant glioma	0.000708	0.00779	CbGeAlD
Imipramine—Liver function test abnormal—Carmustine—malignant glioma	0.000703	0.0102	CcSEcCtD
Imipramine—Mood swings—Temozolomide—malignant glioma	0.000697	0.0101	CcSEcCtD
Imipramine—Ataxia—Temozolomide—malignant glioma	0.000692	0.01	CcSEcCtD
Imipramine—Breast disorder—Temozolomide—malignant glioma	0.000665	0.00961	CcSEcCtD
Imipramine—SLC22A3—embryo—malignant glioma	0.000655	0.00722	CbGeAlD
Imipramine—SLC6A3—brainstem—malignant glioma	0.000638	0.00702	CbGeAlD
Imipramine—KCND3—central nervous system—malignant glioma	0.000631	0.00695	CbGeAlD
Imipramine—Pancytopenia—Carmustine—malignant glioma	0.000625	0.00903	CcSEcCtD
Imipramine—KCND3—cerebellum—malignant glioma	0.000617	0.0068	CbGeAlD
Imipramine—HTR2C—brainstem—malignant glioma	0.000617	0.00679	CbGeAlD
Imipramine—HTR2A—endothelium—malignant glioma	0.000614	0.00676	CbGeAlD
Imipramine—Pancytopenia—Temozolomide—malignant glioma	0.000604	0.00873	CcSEcCtD
Imipramine—CHRM4—central nervous system—malignant glioma	0.000601	0.00662	CbGeAlD
Imipramine—Pollakiuria—Temozolomide—malignant glioma	0.000588	0.00849	CcSEcCtD
Imipramine—Erectile dysfunction—Temozolomide—malignant glioma	0.000586	0.00847	CcSEcCtD
Imipramine—SLC6A4—brainstem—malignant glioma	0.000584	0.00644	CbGeAlD
Imipramine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000581	0.00839	CcSEcCtD
Imipramine—Weight increased—Temozolomide—malignant glioma	0.000579	0.00837	CcSEcCtD
Imipramine—Weight decreased—Temozolomide—malignant glioma	0.000575	0.00832	CcSEcCtD
Imipramine—Neuropathy peripheral—Carmustine—malignant glioma	0.000575	0.00831	CcSEcCtD
Imipramine—KCND2—brain—malignant glioma	0.000575	0.00633	CbGeAlD
Imipramine—Stomatitis—Carmustine—malignant glioma	0.000572	0.00827	CcSEcCtD
Imipramine—CHRM2—telencephalon—malignant glioma	0.000568	0.00625	CbGeAlD
Imipramine—Infestation—Temozolomide—malignant glioma	0.000567	0.0082	CcSEcCtD
Imipramine—Infestation NOS—Temozolomide—malignant glioma	0.000567	0.0082	CcSEcCtD
Imipramine—SLC6A3—telencephalon—malignant glioma	0.000566	0.00623	CbGeAlD
Imipramine—HTR2A—blood vessel—malignant glioma	0.000566	0.00623	CbGeAlD
Imipramine—SLC22A1—telencephalon—malignant glioma	0.000558	0.00614	CbGeAlD
Imipramine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000556	0.00803	CcSEcCtD
Imipramine—Stomatitis—Temozolomide—malignant glioma	0.000553	0.00799	CcSEcCtD
Imipramine—HTR2C—telencephalon—malignant glioma	0.000547	0.00603	CbGeAlD
Imipramine—HTR6—central nervous system—malignant glioma	0.000538	0.00593	CbGeAlD
Imipramine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000536	0.00775	CcSEcCtD
Imipramine—Hypoaesthesia—Carmustine—malignant glioma	0.000524	0.00758	CcSEcCtD
Imipramine—Hallucination—Carmustine—malignant glioma	0.000524	0.00758	CcSEcCtD
Imipramine—HTR1A—brainstem—malignant glioma	0.000519	0.00571	CbGeAlD
Imipramine—SLC6A4—telencephalon—malignant glioma	0.000519	0.00571	CbGeAlD
Imipramine—CHRM1—telencephalon—malignant glioma	0.000517	0.00569	CbGeAlD
Imipramine—SLC6A2—brainstem—malignant glioma	0.000515	0.00567	CbGeAlD
Imipramine—Hepatitis—Temozolomide—malignant glioma	0.000509	0.00736	CcSEcCtD
Imipramine—Hallucination—Temozolomide—malignant glioma	0.000507	0.00732	CcSEcCtD
Imipramine—Hypoaesthesia—Temozolomide—malignant glioma	0.000507	0.00732	CcSEcCtD
Imipramine—Urinary tract disorder—Temozolomide—malignant glioma	0.000503	0.00727	CcSEcCtD
Imipramine—KCND3—brain—malignant glioma	0.000501	0.00552	CbGeAlD
Imipramine—Urethral disorder—Temozolomide—malignant glioma	0.000499	0.00721	CcSEcCtD
Imipramine—HTR7—brainstem—malignant glioma	0.000496	0.00546	CbGeAlD
Imipramine—Eye disorder—Carmustine—malignant glioma	0.000492	0.00712	CcSEcCtD
Imipramine—Flushing—Carmustine—malignant glioma	0.000489	0.00707	CcSEcCtD
Imipramine—Amitriptyline—NTRK2—malignant glioma	0.00048	0.104	CrCbGaD
Imipramine—ADRA1A—brainstem—malignant glioma	0.000478	0.00527	CbGeAlD
Imipramine—CHRM4—brain—malignant glioma	0.000477	0.00526	CbGeAlD
Imipramine—Eye disorder—Temozolomide—malignant glioma	0.000476	0.00688	CcSEcCtD
Imipramine—Tinnitus—Temozolomide—malignant glioma	0.000475	0.00686	CcSEcCtD
Imipramine—Cardiac disorder—Temozolomide—malignant glioma	0.000472	0.00683	CcSEcCtD
Imipramine—Flushing—Temozolomide—malignant glioma	0.000472	0.00683	CcSEcCtD
Imipramine—Arrhythmia—Carmustine—malignant glioma	0.000471	0.0068	CcSEcCtD
Imipramine—CHRM5—central nervous system—malignant glioma	0.00047	0.00518	CbGeAlD
Imipramine—DRD2—brainstem—malignant glioma	0.000469	0.00516	CbGeAlD
Imipramine—Alopecia—Carmustine—malignant glioma	0.000466	0.00673	CcSEcCtD
Imipramine—CHRM3—telencephalon—malignant glioma	0.000462	0.00509	CbGeAlD
Imipramine—Angiopathy—Temozolomide—malignant glioma	0.000462	0.00668	CcSEcCtD
Imipramine—Mental disorder—Carmustine—malignant glioma	0.000462	0.00667	CcSEcCtD
Imipramine—HTR1A—telencephalon—malignant glioma	0.000461	0.00507	CbGeAlD
Imipramine—Immune system disorder—Temozolomide—malignant glioma	0.00046	0.00665	CcSEcCtD
Imipramine—Mediastinal disorder—Temozolomide—malignant glioma	0.000459	0.00663	CcSEcCtD
Imipramine—Malnutrition—Carmustine—malignant glioma	0.000459	0.00663	CcSEcCtD
Imipramine—SLC6A2—telencephalon—malignant glioma	0.000457	0.00503	CbGeAlD
Imipramine—DRD2—retina—malignant glioma	0.000452	0.00498	CbGeAlD
Imipramine—Alopecia—Temozolomide—malignant glioma	0.00045	0.0065	CcSEcCtD
Imipramine—Mental disorder—Temozolomide—malignant glioma	0.000446	0.00645	CcSEcCtD
Imipramine—Malnutrition—Temozolomide—malignant glioma	0.000443	0.0064	CcSEcCtD
Imipramine—HTR7—telencephalon—malignant glioma	0.00044	0.00485	CbGeAlD
Imipramine—Dysgeusia—Temozolomide—malignant glioma	0.000434	0.00627	CcSEcCtD
Imipramine—Vision blurred—Carmustine—malignant glioma	0.000432	0.00625	CcSEcCtD
Imipramine—HTR2C—medulla oblongata—malignant glioma	0.00043	0.00473	CbGeAlD
Imipramine—Tremor—Carmustine—malignant glioma	0.00043	0.00621	CcSEcCtD
Imipramine—ADRA1B—central nervous system—malignant glioma	0.00043	0.00473	CbGeAlD
Imipramine—HTR6—brain—malignant glioma	0.000427	0.00471	CbGeAlD
Imipramine—ORM1—spinal cord—malignant glioma	0.000427	0.0047	CbGeAlD
Imipramine—ADRA1A—telencephalon—malignant glioma	0.000425	0.00468	CbGeAlD
Imipramine—Agitation—Carmustine—malignant glioma	0.000421	0.00609	CcSEcCtD
Imipramine—ADRA1D—central nervous system—malignant glioma	0.00042	0.00463	CbGeAlD
Imipramine—Vision blurred—Temozolomide—malignant glioma	0.000418	0.00604	CcSEcCtD
Imipramine—DRD2—telencephalon—malignant glioma	0.000416	0.00458	CbGeAlD
Imipramine—Tremor—Temozolomide—malignant glioma	0.000415	0.006	CcSEcCtD
Imipramine—Ill-defined disorder—Temozolomide—malignant glioma	0.000411	0.00594	CcSEcCtD
Imipramine—Leukopenia—Carmustine—malignant glioma	0.00041	0.00593	CcSEcCtD
Imipramine—SLC22A4—spinal cord—malignant glioma	0.00041	0.00452	CbGeAlD
Imipramine—KCNH2—telencephalon—malignant glioma	0.00041	0.00452	CbGeAlD
Imipramine—Agitation—Temozolomide—malignant glioma	0.000407	0.00589	CcSEcCtD
Imipramine—SLC6A3—midbrain—malignant glioma	0.000406	0.00448	CbGeAlD
Imipramine—Malaise—Temozolomide—malignant glioma	0.0004	0.00578	CcSEcCtD
Imipramine—Convulsion—Carmustine—malignant glioma	0.000397	0.00574	CcSEcCtD
Imipramine—Leukopenia—Temozolomide—malignant glioma	0.000397	0.00573	CcSEcCtD
Imipramine—SLC6A3—spinal cord—malignant glioma	0.000397	0.00437	CbGeAlD
Imipramine—Hypertension—Carmustine—malignant glioma	0.000396	0.00572	CcSEcCtD
Imipramine—HTR2C—midbrain—malignant glioma	0.000393	0.00433	CbGeAlD
Imipramine—Palpitations—Temozolomide—malignant glioma	0.000392	0.00566	CcSEcCtD
Imipramine—Anxiety—Carmustine—malignant glioma	0.000389	0.00562	CcSEcCtD
Imipramine—Convulsion—Temozolomide—malignant glioma	0.000384	0.00555	CcSEcCtD
Imipramine—HTR2C—spinal cord—malignant glioma	0.000383	0.00422	CbGeAlD
Imipramine—Hypertension—Temozolomide—malignant glioma	0.000383	0.00553	CcSEcCtD
Imipramine—Confusional state—Carmustine—malignant glioma	0.000377	0.00545	CcSEcCtD
Imipramine—Anxiety—Temozolomide—malignant glioma	0.000376	0.00543	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000375	0.00542	CcSEcCtD
Imipramine—Oedema—Carmustine—malignant glioma	0.000374	0.00541	CcSEcCtD
Imipramine—CHRM5—brain—malignant glioma	0.000373	0.00411	CbGeAlD
Imipramine—Discomfort—Temozolomide—malignant glioma	0.000373	0.00539	CcSEcCtD
Imipramine—SLC6A4—midbrain—malignant glioma	0.000373	0.0041	CbGeAlD
Imipramine—Infection—Carmustine—malignant glioma	0.000372	0.00537	CcSEcCtD
Imipramine—ABCB1—blood vessel—malignant glioma	0.000371	0.00408	CbGeAlD
Imipramine—Dry mouth—Temozolomide—malignant glioma	0.000369	0.00533	CcSEcCtD
Imipramine—Thrombocytopenia—Carmustine—malignant glioma	0.000366	0.0053	CcSEcCtD
Imipramine—Tachycardia—Carmustine—malignant glioma	0.000365	0.00528	CcSEcCtD
Imipramine—Confusional state—Temozolomide—malignant glioma	0.000365	0.00527	CcSEcCtD
Imipramine—SLC6A4—spinal cord—malignant glioma	0.000363	0.004	CbGeAlD
Imipramine—Epinastine—CYP2B6—malignant glioma	0.000362	0.0787	CrCbGaD
Imipramine—Oedema—Temozolomide—malignant glioma	0.000362	0.00523	CcSEcCtD
Imipramine—Anaphylactic shock—Temozolomide—malignant glioma	0.000362	0.00523	CcSEcCtD
Imipramine—Infection—Temozolomide—malignant glioma	0.000359	0.00519	CcSEcCtD
Imipramine—SLC6A2—medulla oblongata—malignant glioma	0.000359	0.00395	CbGeAlD
Imipramine—Anorexia—Carmustine—malignant glioma	0.000357	0.00516	CcSEcCtD
Imipramine—Nervous system disorder—Temozolomide—malignant glioma	0.000355	0.00513	CcSEcCtD
Imipramine—Thrombocytopenia—Temozolomide—malignant glioma	0.000354	0.00512	CcSEcCtD
Imipramine—Skin disorder—Temozolomide—malignant glioma	0.000351	0.00508	CcSEcCtD
Imipramine—Hyperhidrosis—Temozolomide—malignant glioma	0.00035	0.00505	CcSEcCtD
Imipramine—ORM1—central nervous system—malignant glioma	0.000346	0.00381	CbGeAlD
Imipramine—HTR7—medulla oblongata—malignant glioma	0.000346	0.00381	CbGeAlD
Imipramine—Anorexia—Temozolomide—malignant glioma	0.000345	0.00498	CcSEcCtD
Imipramine—ADRA1B—brain—malignant glioma	0.000341	0.00376	CbGeAlD
Imipramine—Insomnia—Carmustine—malignant glioma	0.000339	0.00489	CcSEcCtD
Imipramine—HTR2A—embryo—malignant glioma	0.000337	0.00372	CbGeAlD
Imipramine—Paraesthesia—Carmustine—malignant glioma	0.000336	0.00486	CcSEcCtD
Imipramine—ADRA1D—brain—malignant glioma	0.000334	0.00367	CbGeAlD
Imipramine—Somnolence—Carmustine—malignant glioma	0.000333	0.00481	CcSEcCtD
Imipramine—HTR1A—midbrain—malignant glioma	0.000331	0.00364	CbGeAlD
Imipramine—HRH1—telencephalon—malignant glioma	0.000329	0.00362	CbGeAlD
Imipramine—Insomnia—Temozolomide—malignant glioma	0.000327	0.00473	CcSEcCtD
Imipramine—Decreased appetite—Carmustine—malignant glioma	0.000325	0.0047	CcSEcCtD
Imipramine—SLC22A4—cerebellum—malignant glioma	0.000325	0.00358	CbGeAlD
Imipramine—Paraesthesia—Temozolomide—malignant glioma	0.000325	0.00469	CcSEcCtD
Imipramine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000323	0.00467	CcSEcCtD
Imipramine—HTR1A—spinal cord—malignant glioma	0.000323	0.00355	CbGeAlD
Imipramine—CHRM2—central nervous system—malignant glioma	0.000323	0.00355	CbGeAlD
Imipramine—KCNH2—medulla oblongata—malignant glioma	0.000322	0.00355	CbGeAlD
Imipramine—SLC6A3—central nervous system—malignant glioma	0.000322	0.00354	CbGeAlD
Imipramine—Somnolence—Temozolomide—malignant glioma	0.000322	0.00465	CcSEcCtD
Imipramine—Constipation—Carmustine—malignant glioma	0.00032	0.00463	CcSEcCtD
Imipramine—Dyspepsia—Temozolomide—malignant glioma	0.000318	0.0046	CcSEcCtD
Imipramine—SLC22A1—central nervous system—malignant glioma	0.000317	0.00349	CbGeAlD
Imipramine—HTR7—midbrain—malignant glioma	0.000316	0.00348	CbGeAlD
Imipramine—CYP2E1—telencephalon—malignant glioma	0.000316	0.00348	CbGeAlD
Imipramine—SLC6A3—cerebellum—malignant glioma	0.000314	0.00346	CbGeAlD
Imipramine—Decreased appetite—Temozolomide—malignant glioma	0.000314	0.00454	CcSEcCtD
Imipramine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000312	0.00451	CcSEcCtD
Imipramine—Fatigue—Temozolomide—malignant glioma	0.000312	0.00451	CcSEcCtD
Imipramine—HTR2C—central nervous system—malignant glioma	0.000311	0.00342	CbGeAlD
Imipramine—Constipation—Temozolomide—malignant glioma	0.000309	0.00447	CcSEcCtD
Imipramine—HTR2A—brainstem—malignant glioma	0.000309	0.00341	CbGeAlD
Imipramine—Feeling abnormal—Carmustine—malignant glioma	0.000308	0.00446	CcSEcCtD
Imipramine—HTR7—spinal cord—malignant glioma	0.000308	0.0034	CbGeAlD
Imipramine—Gastrointestinal pain—Carmustine—malignant glioma	0.000306	0.00442	CcSEcCtD
Imipramine—SLC22A3—central nervous system—malignant glioma	0.000303	0.00334	CbGeAlD
Imipramine—DRD2—midbrain—malignant glioma	0.000299	0.00329	CbGeAlD
Imipramine—HTR2A—retina—malignant glioma	0.000298	0.00329	CbGeAlD
Imipramine—Feeling abnormal—Temozolomide—malignant glioma	0.000298	0.00431	CcSEcCtD
Imipramine—Amitriptyline—NTRK1—malignant glioma	0.000296	0.0645	CrCbGaD
Imipramine—Body temperature increased—Carmustine—malignant glioma	0.000296	0.00428	CcSEcCtD
Imipramine—Abdominal pain—Carmustine—malignant glioma	0.000296	0.00428	CcSEcCtD
Imipramine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000296	0.00427	CcSEcCtD
Imipramine—SLC6A4—central nervous system—malignant glioma	0.000295	0.00325	CbGeAlD
Imipramine—KCNH2—midbrain—malignant glioma	0.000294	0.00324	CbGeAlD
Imipramine—CHRM1—central nervous system—malignant glioma	0.000294	0.00323	CbGeAlD
Imipramine—Urticaria—Temozolomide—malignant glioma	0.000287	0.00415	CcSEcCtD
Imipramine—KCNH2—spinal cord—malignant glioma	0.000287	0.00316	CbGeAlD
Imipramine—Body temperature increased—Temozolomide—malignant glioma	0.000286	0.00413	CcSEcCtD
Imipramine—Abdominal pain—Temozolomide—malignant glioma	0.000286	0.00413	CcSEcCtD
Imipramine—CYP2D6—brainstem—malignant glioma	0.000282	0.0031	CbGeAlD
Imipramine—HTR2A—telencephalon—malignant glioma	0.000274	0.00302	CbGeAlD
Imipramine—Ethopropazine—BCHE—malignant glioma	0.000271	0.059	CrCbGaD
Imipramine—Asthenia—Carmustine—malignant glioma	0.000269	0.00388	CcSEcCtD
Imipramine—Maprotiline—SLC6A3—malignant glioma	0.000265	0.0578	CrCbGaD
Imipramine—SLC22A4—brain—malignant glioma	0.000264	0.00291	CbGeAlD
Imipramine—CHRM3—central nervous system—malignant glioma	0.000263	0.00289	CbGeAlD
Imipramine—HTR1A—central nervous system—malignant glioma	0.000262	0.00288	CbGeAlD
Imipramine—SLC6A2—central nervous system—malignant glioma	0.00026	0.00286	CbGeAlD
Imipramine—Asthenia—Temozolomide—malignant glioma	0.00026	0.00375	CcSEcCtD
Imipramine—CHRM2—brain—malignant glioma	0.000256	0.00282	CbGeAlD
Imipramine—Diarrhoea—Carmustine—malignant glioma	0.000256	0.0037	CcSEcCtD
Imipramine—Pruritus—Temozolomide—malignant glioma	0.000256	0.0037	CcSEcCtD
Imipramine—HTR1A—cerebellum—malignant glioma	0.000256	0.00282	CbGeAlD
Imipramine—SLC6A3—brain—malignant glioma	0.000255	0.00281	CbGeAlD
Imipramine—SLC22A1—brain—malignant glioma	0.000252	0.00277	CbGeAlD
Imipramine—HTR7—central nervous system—malignant glioma	0.00025	0.00275	CbGeAlD
Imipramine—CYP2D6—telencephalon—malignant glioma	0.00025	0.00275	CbGeAlD
Imipramine—CYP2E1—medulla oblongata—malignant glioma	0.000248	0.00273	CbGeAlD
Imipramine—Dizziness—Carmustine—malignant glioma	0.000247	0.00358	CcSEcCtD
Imipramine—Diarrhoea—Temozolomide—malignant glioma	0.000247	0.00358	CcSEcCtD
Imipramine—HTR2C—brain—malignant glioma	0.000247	0.00272	CbGeAlD
Imipramine—HTR7—cerebellum—malignant glioma	0.000245	0.00269	CbGeAlD
Imipramine—ADRA1A—central nervous system—malignant glioma	0.000241	0.00266	CbGeAlD
Imipramine—SLC22A3—brain—malignant glioma	0.00024	0.00265	CbGeAlD
Imipramine—Dizziness—Temozolomide—malignant glioma	0.000239	0.00346	CcSEcCtD
Imipramine—Vomiting—Carmustine—malignant glioma	0.000238	0.00344	CcSEcCtD
Imipramine—DRD2—central nervous system—malignant glioma	0.000237	0.0026	CbGeAlD
Imipramine—Rash—Carmustine—malignant glioma	0.000236	0.00341	CcSEcCtD
Imipramine—ADRA1A—cerebellum—malignant glioma	0.000236	0.0026	CbGeAlD
Imipramine—Dermatitis—Carmustine—malignant glioma	0.000236	0.00341	CcSEcCtD
Imipramine—Headache—Carmustine—malignant glioma	0.000234	0.00339	CcSEcCtD
Imipramine—SLC6A4—brain—malignant glioma	0.000234	0.00258	CbGeAlD
Imipramine—CHRM1—brain—malignant glioma	0.000233	0.00257	CbGeAlD
Imipramine—Diphenhydramine—CYP2C18—malignant glioma	0.000233	0.0507	CrCbGaD
Imipramine—KCNH2—central nervous system—malignant glioma	0.000233	0.00257	CbGeAlD
Imipramine—DRD2—cerebellum—malignant glioma	0.000231	0.00255	CbGeAlD
Imipramine—Vomiting—Temozolomide—malignant glioma	0.00023	0.00332	CcSEcCtD
Imipramine—Rash—Temozolomide—malignant glioma	0.000228	0.0033	CcSEcCtD
Imipramine—Dermatitis—Temozolomide—malignant glioma	0.000228	0.00329	CcSEcCtD
Imipramine—KCNH2—cerebellum—malignant glioma	0.000228	0.00251	CbGeAlD
Imipramine—Clomipramine—GSTP1—malignant glioma	0.000228	0.0495	CrCbGaD
Imipramine—Carbamazepine—CYP2B6—malignant glioma	0.000227	0.0494	CrCbGaD
Imipramine—Headache—Temozolomide—malignant glioma	0.000227	0.00327	CcSEcCtD
Imipramine—Nausea—Carmustine—malignant glioma	0.000222	0.00321	CcSEcCtD
Imipramine—Triflupromazine—BCHE—malignant glioma	0.000222	0.0484	CrCbGaD
Imipramine—CYP2E1—spinal cord—malignant glioma	0.000221	0.00244	CbGeAlD
Imipramine—ABCB1—embryo—malignant glioma	0.000221	0.00244	CbGeAlD
Imipramine—HTR2A—medulla oblongata—malignant glioma	0.000216	0.00237	CbGeAlD
Imipramine—Nausea—Temozolomide—malignant glioma	0.000215	0.0031	CcSEcCtD
Imipramine—Mianserin—CYP2B6—malignant glioma	0.000209	0.0456	CrCbGaD
Imipramine—CHRM3—brain—malignant glioma	0.000209	0.0023	CbGeAlD
Imipramine—HTR1A—brain—malignant glioma	0.000208	0.00229	CbGeAlD
Imipramine—Desipramine—CYP2C18—malignant glioma	0.000208	0.0452	CrCbGaD
Imipramine—SLC6A2—brain—malignant glioma	0.000206	0.00227	CbGeAlD
Imipramine—HTR7—brain—malignant glioma	0.000199	0.00219	CbGeAlD
Imipramine—HTR2A—midbrain—malignant glioma	0.000197	0.00217	CbGeAlD
Imipramine—ABCB1—retina—malignant glioma	0.000196	0.00215	CbGeAlD
Imipramine—HTR2A—spinal cord—malignant glioma	0.000192	0.00212	CbGeAlD
Imipramine—ADRA1A—brain—malignant glioma	0.000192	0.00211	CbGeAlD
Imipramine—CYP2B6—central nervous system—malignant glioma	0.000191	0.00211	CbGeAlD
Imipramine—DRD2—brain—malignant glioma	0.000188	0.00207	CbGeAlD
Imipramine—HRH1—central nervous system—malignant glioma	0.000187	0.00206	CbGeAlD
Imipramine—KCNH2—brain—malignant glioma	0.000185	0.00204	CbGeAlD
Imipramine—ABCB1—telencephalon—malignant glioma	0.00018	0.00198	CbGeAlD
Imipramine—CYP2E1—central nervous system—malignant glioma	0.000179	0.00198	CbGeAlD
Imipramine—Mianserin—SLC6A3—malignant glioma	0.000178	0.0388	CrCbGaD
Imipramine—CYP2E1—cerebellum—malignant glioma	0.000175	0.00193	CbGeAlD
Imipramine—Diphenhydramine—CYP2B6—malignant glioma	0.000173	0.0376	CrCbGaD
Imipramine—Promethazine—CYP2B6—malignant glioma	0.00017	0.0369	CrCbGaD
Imipramine—Orphenadrine—CYP2B6—malignant glioma	0.000164	0.0356	CrCbGaD
Imipramine—HTR2A—central nervous system—malignant glioma	0.000156	0.00172	CbGeAlD
Imipramine—Desipramine—CYP2B6—malignant glioma	0.000154	0.0335	CrCbGaD
Imipramine—HTR2A—cerebellum—malignant glioma	0.000152	0.00168	CbGeAlD
Imipramine—CYP2B6—brain—malignant glioma	0.000152	0.00167	CbGeAlD
Imipramine—Trimipramine—SLC6A3—malignant glioma	0.00015	0.0327	CrCbGaD
Imipramine—HRH1—brain—malignant glioma	0.000148	0.00163	CbGeAlD
Imipramine—CYP3A4—central nervous system—malignant glioma	0.000144	0.00159	CbGeAlD
Imipramine—CYP2E1—brain—malignant glioma	0.000143	0.00157	CbGeAlD
Imipramine—CYP2D6—central nervous system—malignant glioma	0.000142	0.00157	CbGeAlD
Imipramine—ABCB1—medulla oblongata—malignant glioma	0.000141	0.00156	CbGeAlD
Imipramine—CYP2D6—cerebellum—malignant glioma	0.000139	0.00153	CbGeAlD
Imipramine—Desipramine—SLC6A3—malignant glioma	0.000131	0.0286	CrCbGaD
Imipramine—Amitriptyline—CYP2B6—malignant glioma	0.00013	0.0283	CrCbGaD
Imipramine—ABCB1—midbrain—malignant glioma	0.000129	0.00142	CbGeAlD
Imipramine—ABCB1—spinal cord—malignant glioma	0.000126	0.00139	CbGeAlD
Imipramine—HTR2A—brain—malignant glioma	0.000124	0.00136	CbGeAlD
Imipramine—Nortriptyline—PTGS1—malignant glioma	0.000123	0.0268	CrCbGaD
Imipramine—Diphenhydramine—PTGS1—malignant glioma	0.000114	0.0248	CrCbGaD
Imipramine—CYP2D6—brain—malignant glioma	0.000113	0.00124	CbGeAlD
Imipramine—Chlorpromazine—BCHE—malignant glioma	0.000107	0.0233	CrCbGaD
Imipramine—ABCB1—central nervous system—malignant glioma	0.000102	0.00113	CbGeAlD
Imipramine—ABCB1—cerebellum—malignant glioma	9.99e-05	0.0011	CbGeAlD
Imipramine—ABCB1—brain—malignant glioma	8.12e-05	0.000894	CbGeAlD
Imipramine—HRH1—Signaling Pathways—RAF1—malignant glioma	3.15e-06	3.26e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CB—malignant glioma	3.14e-06	3.25e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.14e-06	3.25e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.14e-06	3.25e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.13e-06	3.24e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAV1—malignant glioma	3.13e-06	3.24e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.13e-06	3.24e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—malignant glioma	3.12e-06	3.24e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	3.12e-06	3.23e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.12e-06	3.23e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.12e-06	3.23e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL2—malignant glioma	3.12e-06	3.23e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ERBB2—malignant glioma	3.11e-06	3.23e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—malignant glioma	3.11e-06	3.22e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3.11e-06	3.22e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.11e-06	3.22e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.1e-06	3.22e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	3.1e-06	3.21e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MMP9—malignant glioma	3.1e-06	3.21e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.1e-06	3.21e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.1e-06	3.21e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.09e-06	3.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.09e-06	3.2e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.08e-06	3.19e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PTEN—malignant glioma	3.08e-06	3.19e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.08e-06	3.19e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.08e-06	3.19e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	3.07e-06	3.18e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.06e-06	3.17e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.06e-06	3.17e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.06e-06	3.17e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.06e-06	3.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	3.06e-06	3.16e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.05e-06	3.16e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—malignant glioma	3.05e-06	3.16e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CG—malignant glioma	3.02e-06	3.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.02e-06	3.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	3.02e-06	3.12e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KRAS—malignant glioma	3.01e-06	3.12e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.01e-06	3.12e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	3e-06	3.11e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—malignant glioma	2.99e-06	3.1e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.99e-06	3.1e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.96e-06	3.07e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.95e-06	3.06e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.95e-06	3.06e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	2.94e-06	3.05e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—malignant glioma	2.94e-06	3.04e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	2.94e-06	3.04e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	2.93e-06	3.04e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.93e-06	3.04e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	2.93e-06	3.04e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—malignant glioma	2.92e-06	3.02e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.91e-06	3.01e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.91e-06	3.01e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.9e-06	3e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KRAS—malignant glioma	2.89e-06	2.99e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.88e-06	2.98e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL2—malignant glioma	2.87e-06	2.98e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	2.87e-06	2.98e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	2.86e-06	2.96e-05	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.86e-06	2.96e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.85e-06	2.95e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.85e-06	2.95e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	2.84e-06	2.95e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—malignant glioma	2.84e-06	2.94e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—malignant glioma	2.84e-06	2.94e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	2.83e-06	2.94e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.83e-06	2.93e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.83e-06	2.93e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.83e-06	2.93e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL2—malignant glioma	2.82e-06	2.92e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—malignant glioma	2.82e-06	2.92e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL2—malignant glioma	2.81e-06	2.91e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—malignant glioma	2.81e-06	2.91e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.81e-06	2.91e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL2—malignant glioma	2.8e-06	2.9e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.8e-06	2.9e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.78e-06	2.88e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.78e-06	2.88e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.78e-06	2.88e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.77e-06	2.87e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.77e-06	2.87e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	2.77e-06	2.87e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.77e-06	2.87e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.75e-06	2.85e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—malignant glioma	2.75e-06	2.85e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.74e-06	2.84e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.73e-06	2.83e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.72e-06	2.82e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.72e-06	2.82e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTEN—malignant glioma	2.71e-06	2.81e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.71e-06	2.81e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.7e-06	2.8e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—malignant glioma	2.68e-06	2.77e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.68e-06	2.77e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.67e-06	2.77e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MMP9—malignant glioma	2.66e-06	2.76e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.66e-06	2.76e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTEN—malignant glioma	2.66e-06	2.75e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CD—malignant glioma	2.66e-06	2.75e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—malignant glioma	2.66e-06	2.75e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.66e-06	2.75e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MMP9—malignant glioma	2.65e-06	2.75e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	2.65e-06	2.75e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAV1—malignant glioma	2.65e-06	2.74e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2.65e-06	2.74e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.65e-06	2.74e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.64e-06	2.73e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTEN—malignant glioma	2.64e-06	2.73e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.63e-06	2.72e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	2.62e-06	2.72e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.62e-06	2.71e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.61e-06	2.71e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.61e-06	2.7e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.6e-06	2.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.59e-06	2.68e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.59e-06	2.68e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.59e-06	2.68e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.58e-06	2.67e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.57e-06	2.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—malignant glioma	2.57e-06	2.66e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.56e-06	2.65e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.55e-06	2.64e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.55e-06	2.64e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.54e-06	2.63e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.53e-06	2.62e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.51e-06	2.6e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.5e-06	2.59e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.5e-06	2.59e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	2.49e-06	2.58e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.49e-06	2.58e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.44e-06	2.53e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—malignant glioma	2.44e-06	2.53e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.42e-06	2.51e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.41e-06	2.5e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—malignant glioma	2.41e-06	2.5e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.41e-06	2.5e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.4e-06	2.49e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.4e-06	2.48e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—malignant glioma	2.4e-06	2.48e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—malignant glioma	2.4e-06	2.48e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.39e-06	2.48e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	2.38e-06	2.47e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.38e-06	2.47e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.38e-06	2.47e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.37e-06	2.46e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.37e-06	2.46e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.37e-06	2.45e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.37e-06	2.45e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.36e-06	2.44e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.36e-06	2.44e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.35e-06	2.44e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.35e-06	2.44e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—malignant glioma	2.35e-06	2.44e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.34e-06	2.42e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.33e-06	2.41e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—malignant glioma	2.33e-06	2.41e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CB—malignant glioma	2.32e-06	2.4e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—malignant glioma	2.3e-06	2.38e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—malignant glioma	2.26e-06	2.34e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	2.25e-06	2.33e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—malignant glioma	2.25e-06	2.33e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—malignant glioma	2.23e-06	2.31e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.21e-06	2.29e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—malignant glioma	2.21e-06	2.29e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.2e-06	2.28e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.2e-06	2.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—malignant glioma	2.19e-06	2.27e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.18e-06	2.26e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.17e-06	2.25e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.17e-06	2.25e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.17e-06	2.24e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.17e-06	2.24e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.16e-06	2.24e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.16e-06	2.24e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.16e-06	2.24e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.16e-06	2.24e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.15e-06	2.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.14e-06	2.22e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.12e-06	2.2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.12e-06	2.2e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.12e-06	2.19e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—malignant glioma	2.12e-06	2.19e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—malignant glioma	2.11e-06	2.19e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—malignant glioma	2.1e-06	2.18e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.09e-06	2.17e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.08e-06	2.15e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	2.07e-06	2.14e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTEN—malignant glioma	2.05e-06	2.12e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAV1—malignant glioma	2.05e-06	2.12e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.04e-06	2.12e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—malignant glioma	2.04e-06	2.11e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	2.04e-06	2.11e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.03e-06	2.11e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.03e-06	2.1e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.01e-06	2.08e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTEN—malignant glioma	2e-06	2.07e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—malignant glioma	2e-06	2.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2e-06	2.07e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—malignant glioma	1.97e-06	2.04e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—malignant glioma	1.91e-06	1.98e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.91e-06	1.98e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTEN—malignant glioma	1.89e-06	1.95e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.88e-06	1.94e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.88e-06	1.94e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.87e-06	1.94e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.87e-06	1.93e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.86e-06	1.93e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.86e-06	1.93e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.85e-06	1.92e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—malignant glioma	1.85e-06	1.91e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.84e-06	1.91e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.84e-06	1.9e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.83e-06	1.9e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—malignant glioma	1.82e-06	1.88e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.82e-06	1.88e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—malignant glioma	1.81e-06	1.88e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.81e-06	1.87e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.8e-06	1.87e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—malignant glioma	1.8e-06	1.86e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.78e-06	1.85e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.78e-06	1.84e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.78e-06	1.84e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.77e-06	1.83e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.69e-06	1.75e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.64e-06	1.7e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTEN—malignant glioma	1.6e-06	1.66e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—malignant glioma	1.56e-06	1.62e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.56e-06	1.61e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.53e-06	1.59e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—malignant glioma	1.53e-06	1.59e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.53e-06	1.59e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.53e-06	1.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.52e-06	1.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.51e-06	1.56e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.5e-06	1.56e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.45e-06	1.5e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.43e-06	1.48e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.41e-06	1.47e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.41e-06	1.46e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.33e-06	1.38e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTEN—malignant glioma	1.23e-06	1.28e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—malignant glioma	1.18e-06	1.22e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—malignant glioma	1.15e-06	1.2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.13e-06	1.17e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—malignant glioma	1.09e-06	1.13e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—malignant glioma	9.21e-07	9.54e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.7e-07	9.01e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—malignant glioma	7.11e-07	7.36e-06	CbGpPWpGaD
